the aid library

Filter

13653

Using recency assays for HIV surveillance: 2022 technical guidance

World Health Organization WHO (2022) C_WHO

Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat... more

Bridging the gap between ethics and decision-making in pandemics - Report of the WHO Pandemic Ethics and Policy Summit

World Health Organization WHO OCHA Services reliefweb (2022) C_WHO

The COVID-19 pandemic has raised profound ethical challenges on an unprecedented global scale. These challenges include how to allocate scarce resources (especially vaccines and therapeutics), both within and between countries, whether and when to mandate vaccines and/or masks, whether and how to co... more

Indicators and questions for monitoring progress on the 2021 Political Declaration on HIV and AIDS — Global AIDS Monitoring 2023

UNAIDS (2022) C_WHO

The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are encouraged to integrate these indicators and questions... more

Informal consultation on end-game challenges for trachoma elimination

World Health Organization WHO (2022) C_WHO

Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass drug administration (MDA), in each form... more

Trachoma Action Planning

International Coalition for Trachoma Control ICTC (2020) CC

This Trachoma Action Planning – a planning guide – is published by the International Coalition for Trachoma Control at the request of the World Health Organization Alliance for the Global Elimination of Trachoma by 2020.

Harmonized health facility assessment (‎HHFA)‎: comprehensive guide

World Health Organisation (WHO) (2023) C_WHO

The HHFA Comprehensive guide serves as the main reference document for planning and implementing a country HHFA. This guide will promote understanding of: What the HHFA is and the information it can and cannot provide. The HHFA modules, questionnaires and CSPro electronic data collection tool. Th... more

Meeting of the Strategic Advisory Group of Experts on Immunization, October 2022: conclusions and recommendations

World Health Organisation (WHO) (2023) C_WHO

The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations. It covers the following items: Global Reports Immunization Agenda 2030 and Regional reports Monkeypox RSV COVID-19 vacci... more

Implementing the SAFE Strategy for Trachoma Control

Center for Disease Control and Prevention CDC (2006) CC

Trachoma causes more vision loss and blindness than any other infection in the world. This disease is caused by Chlamydia trachomatis bacteria. Other variants or strains of these bacteria can cause a sexually transmitted infection (chlamydia) and disease in lymph nodes. This is photomicrograph ... more

“We know about schistosomiasis but we know nothing about FGS”

Mazigo, H.; Sanson, A.; Lambert, V.; et al. (2021) CC

A qualitative assessment of knowledge gaps about female genital schistosomiasis among communities living in Schistosoma haematobium endemic districts of Zanzibar and Northwestern Tanzania. PloS Neglected Tropical Diseases September 30, 2021 https://doi.org/10.1371/journal.pntd.0009789 Schistosoma... more

Increasing access to comprehensive care for Chagas disease: development of a patient-centered model in Colombia

Marchiol, A; Forsyth, C.; Bernal, O.; et al. Pan American Health Organization PAHO (2017) C_WHO

Rev. Panam Salud Publica. 2017;41:e153. doi: 10.26633/RPSP.2017.153 Worldwide, over 6 million people are infected with Trypanosoma cruzi, the pathogen that causes Chagas disease (CD). In the Americas, CD creates the greatest burden in disability-adjusted life years of any parasitic infection. In Co... more

Chagas Access: The pilot experience in Colombia

DNDi Latin America (2021) CC

Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease. Endemic in 21 Latin American countries, the disease can be transmitted by vector insects called triatomines — also known as “kissing bugs” —, foods or beverages contaminated with th... more

Operational manual on leishmaniasis vector control, surveillance, monitoring and evaluation

World Health Organisation (WHO) (2023) C_WHO

Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for... more

An Overview on the Therapeutics of Neglected Infectious Diseases—Leishmaniasis and Chagas Diseases

Brindha, J.; Balamurali, M.; Kaushik, C. Frontiers in Chemistry (2021) C1

Front Chem. 2021; 9: 622286. Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286

Breaking the silence an Opportunity for Patients with Chagas Disease

Moriana, S.; Oritz, G.; Fanjul, G. Chagas Coalition (2016) CC

Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach... more

Organizing trichiasis surgical outreach

International Coalition for Trachoma Control ICTC (2015) CC

A key component of elimination is to reduce the number of unmanaged trachomatous trichiasis cases to less than 1 per 1,000 population in affected areas. This will require not only a large increase in the number of surgeries performed, but also improvements in the quality of surgery and in the e... more

Pénuries et disponibilité des antibiotiques utilisés en santé humaine et vétérinaire en France

World Health Organisation (WHO) (2023) C_WHO

Ce rapport présente une analyse de l'OMS sur les pénuries et le manque de disponibilité des antibiotiques hors brevet en France prenant en compte l'approche Une seule santé. Le rapport est organisé en deux sections : santé animale et santé humaine. Le rapport vise à donner un éclairage sur... more

Prendre soin des soignants

World Health Organisation (WHO) (2021) C_WHO

La santé est un droit humain universel et un facteur essentiel de bien-être, de développement économique, de croissance, de richesse et de prospérité pour tous. Les systèmes de santé jouent un rôle essentiel, car ils protègent, rétablissent et préservent la santé des patients et des p... more

La pénurie mondiale du personnel infirmier et la fidélisation des infirmières

Conseil international des Infirmières (CII) (2021) CC

Un an après le début de la pandémie, la COVID-19 a changé le monde et continue de peser sur notre quotidien. La pandémie a mis en évidence les lacunes des systèmes de santé tandis que le personnel de santé a été exposé au virus de façon disproportionnée. Tout au long de l’année pas... more

Garantir un travail décent au personnel infirmier et aux travailleurs domestiques, acteurs clés de l’économie du soin à autrui

Organisation internationale du Travail (OIT) (2022) CC

Conformément aux dispositions de l’article 19 de la Constitution de l’Organisation internationale du Travail (OIT), le Conseil d’administration, à sa 334e session (octobre-novembre 2018), a décidé que l’Étude d’ensemble qui devait être préparée par la Commission d’experts pour l�... more

Guide pédagogique de l’OMS pour la sécurité des patients

World Health Organisation (WHO) (2011) C_WHO

Le secteur de la santé a beaucoup évolué au cours des 20 dernières années. Les innovations technologiques ainsi que notre connaissance des maladies ont contribué à allonger l’espérance de vie au 20ème siècle. Cependant, l’un des plus grands défis aujourd’hui n’est pas de rester a... more